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Abstract
Background: The Cks1 protein is an essential factor in regulating cell cycle by mediating the ubiquitination of CDK
inhibitor p27kip1. It has been reported that aberrant expression of Cks1 and p27kip1 proteins was found in various
tumors and related to initiation and progression of carcinomas. However, the potential roles which Cks1 and p27KIP1
proteins play in NPC remain unclear. This study aims to examine the expression status of Cks1 and p27kip1 and their
possible prognostic significance in NPC.
Methods: Paraffin-embedded specimens with NPC (n = 168) and non-tumor nasopharyngeal tissues (n = 49) were
analyzed by IHC.
Results: Expression of Cks1 increased in NPC tissues compared with non-tumor nasopharyngeal tissues (P < 0.05),
whereas p27kip1 protein frequently expressed in non-tumor nasopharyngeal tissues compared with NPC tissues
(P < 0.05). There was a significant reverse correlation between Cks1 and p27kip1 protein expression in NPC (r = −0.189,
P < 0.05).In addition, Kaplan-Meier survival curve showed that there was a significant tendency of shorter overall survival
(OS) in NPC patients with Cks1 positive expression compared to negative ones, especially in patients with lymph node
metastasis (P < 0.001, respectively). But there was no significance between p27kip1 expression and survival viability of
NPC patients. Multivariate Cox regression analysis further identified increased expression of Cks1 was the independent
poor prognostic factor for NPC (p = 0.13).
Conclusion: Our research found expression of Cks1 increased and was inverse to the expression of p27KIP1. High
expression of Cks1 was significantly associated with lymph node metastasis and survival status in NPC. In addition, the
abnormally high level of Cks1 protein was proved to be an independent poor prognostic factor in NPC. These results
may provide novel clue for NPC therapy method.
Keywords: Nasopharyngeal carcinoma (NPC), Cyclin-dependent protein kinase regulatory subunit 1 (CKS1), Lymph
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Background
Nasopharyngeal carcinoma (NPC) is a common head and
neck malignancy with a concentrated incidence rate in
Southeast Asia compared with global distribution [1, 2].
Due to its sensibility to radiotherapy, early diagnosis and
radiotherapy alone or in combination with chemotherapy
have remarkably increased NPC survival rate. However,
local recurrence and metastasis frequently lead to failure
of clinical therapy in advanced stage patients [3]. The
initiation and progression of NPC involves various fac-
tors, including Epstein-Barr virus (EBV) infection, gen-
etic susceptibility, exposure to chemical carcinogens
and mutant expression of tumor-suppressor genes, etc
[4, 5]. Over the past decade, essential biomarkers in-
volved in critical genetic events that contribute to the
carcinogenesis of NPC have been increasingly found.
Further investigation of novel factors associated with
prognosis would provide new clue for exploring new ef-
fective therapeutic methods in NPC.
The cyclin–dependent protein kinase regulatory sub-
unit 1 (Cks1) gene which encodes a 9KD protein Cks1
takes important roles in cell growth, proliferation and
apoptosis. The protein Cks1 is an essential adaptor of
the SCF-SKP2 E3 ligase ubiquitin ligase complex which
appends ubiquitin to targets for degradation through the
ubiquitin proteasomal system [6]. One of crucial func-
tional roles of Cks1 is to mediate the ubiquitination of
CDK inhibitor p27Kip1 and lead to promote cell cycle
progression from G1 to S phase [7, 8]. Aberrant expres-
sion of Cks1 and p27KIP1 has been found in multiple hu-
man cancers and is significantly associated with tumor
invasion and metastasis [9–13]. Although Cks1 expres-
sion is generally inversely related to p27Kip1 expression,
but some studies reported different expression pattern
of Cks1 and p27Kip1 proteins which emphasize poten-
tially p27Kip1 independent mechanisms of Cks1 in cancer
progression [14, 15]. The relevance between Cks1 and
p27Kip1 protein and the clinicopathological characteris-
tics in NPC remains unclear. In this present study, we
aimed to identify the expression level of Cks1 and




In this study, 168 cases of paraffin-embedded tissue from
the primary NPC patients and 49 cases of nasopharyn-
geal mucosa tissues from patients with chronic naso-
pharyngitis were obtained from the Second Xiangya
Hospital of Central South University (Changsha, China).
The collection of specimens and study protocol were
approved by the Institutional Human Experiment and
Ethics Committee of the Second Xiangya Hospital of
Central South University.
Complete clinical record and follow-up data from all
NPC patients were collected. None of NPC patients re-
ceived radiotherapy or chemotherapy prior to diagnosis.
Among 168 cases of NPC patients, there were 14 cases
of differentiated non-keratinizing nasopharyngeal carcin-
oma and 154 cases of undifferentiated non-keratinizing
nasopharyngeal carcinoma. The clinical stages and treat-
ments of all patients were as follows: 3 cases of clinical
stage I, 42 cases of stage II, 77 cases of stage III and 46
cases of stage IV; 78 patients treated with radiotherapy,
and 90 patients treated with combined radiotherapy and
chemotherapy. Among these NPC patients in this study,
total 94 patients (55.9%) were alive with a mean follow-
up period of 67 months (3–120 months).
IHC staining
Total of 168 formalin-fixed, paraffin- embedded NPC
and 49 non-tumor nasopharyngeal mucosa tissues were
collected for immunohistochemical analysis. Briefly, each
section was deparaffinized, rehydrated, high-temperature
retrieved by heating slides in citrate buffer (pH 6.0) at
100 °C for 4 min, bathed in 0.3% H2O2 in methanol for
30 min and blocked by 10% preimmune goat serum for
30 min. The slides were incubated with a 1:200 dilution
of primary antibody of Cks1 (Sigma Aldrich) or a 1:200
dilution of primary antibody of p27Kip1 (Abcam Inc.) at
4 °C over-night, and then stained by Ready-to-use Envi-
sion Dual Link System-HRP methods (Dako Inc.) ac-
cording to the instruction. Color reaction was visualized
with Diaminobenzidine (DAB) solution. Counterstaining
was carried out with hematoxylin. Besides the internal
positive control, the positive and negative control slides
were contained in each experiment.
Scoring all slides were performed as described in our
previous publication [16]. All slides were scored manu-
ally by two independent individuals at 200 magnification
light microscopy.
Statistical analyses
All statistical analyses were performed with SPSS 19.0
software. The significance of Cks1 or p27Kip1 proteins
expression in NPC and non-tumor tissues was tested by
χ2-test. The relevance between expression of Cks1 and
p27Kip1 proteins in NPC was analyzed by Spearman’s
rank correlation coefficient. The association between ex-
pression of Cks1 and p27Kip1 proteins and clinicopatho-
logical features in NPC was assessed by the χ2-test.
Survival curves were constructed by using the Kaplan–
Meier method and statistical significance was assessed
by the log-rank test. The prognostic significance of ex-
pression of Cks1 and p27Kip1 proteins was evaluated by
the Cox proportional hazard regression model. P-value
of <0.05 was considered statistically significant.
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Results
Expression of Cks1 protein increased and p27kip1 protein
decreased in NPC
To clarify the significance of Cks1 and p27kip1 proteins
in NPC, we investigated the expression of Cks1 and
p27kip1 in NPC and non-tumor nasopharyngeal tissues
by IHC method. As shown in Fig. 1, positive staining of
Cks1 protein mainly localized in the nucleus and in
73.2% of NPC tissues (Fig. 1a), especially in tumor me-
tastasized in lymph node (Fig. 1b) and 36.7% of normal
nasopharyngeal tissues (Fig. 1c). Staining of p27kip1 pro-
tein was not strong as cks1 protein did in tumor tissues
(Fig. 1d and e), but was positively expressed in 57.1% of
normal nasopharyngeal epithelial tissues (Fig. 1f ). As
shown in Table 1, the statistical data confirmed that
Cks1 protein highly expressed in NPC tissues compared
with non-tumor nasopharyngeal tissues (73% vs. 36%,
P < 0.05), and p27kip1 protein frequently expressed in
non- tumor nasopharyngeal tissues compared with
NPC tissues (57% vs. 43%, P < 0.05).
To examine the relevance between cks1 and p27kip1
protein in NPC, we analyzed data with Spearman’s cor-
relation. In Table 2, the result illustrated that expression
level of Cks1 and p27kip1 protein was significantly in-
verse in NPC (r = −0.189, P < 0.05).
These study results confirmed that expression of Cks1
increased in NPC, and was companied with a reverse ex-
pression of p27kip1 protein.
Increased expression of Cks1 was associated with
clinicopathological features of NPC
To explore if the mutant expression of Cks1 and p27kip1
was associated with clinical outcomes of NPC, we uti-
lized univariate chi-square test to verify the relevance
between Cks1 and p27kip1 proteins expression and NPC
clinicopathological characters. The Table 3 indicated that
NPC tissueswith lymph node metastasis presented
higher expression of Cks1 than those without lymph
node metastasis (p = 0.007), and NPC tissues from pa-
tients of the deceased group possessed higher expression
Fig. 1 Expression of Cks1 and p27KIP1 in NPC and non-tumor nasopharygeal tissues by IHC. Strong staining of Cks1 protein was identified in cell
nuclei of primary NPC tissues (a) and lymph node metastasis tissues (b). Negative staining of Cks1 protein was identified in the normal nasopharyngeal
epithelia (c). Moderate staining of p27KIP1 was found in primary NPC tissues (d) and lymph node metastasis tissues (e). Strong staining of p27KIP1 was
found in cell nuclei of non-tumor nasopharygeal epithelium (f)
Table 1 Expression of Cks1 and p27KIP1 in NPC and non-tumor nasopharygeal tissues
Variable Cks1 Expression p27kip1 Expression
P (%) N (%) *p-value P (%) N (%) *p-value
NPC (n = 168) 123 (73.2) 45 (26.8) .001 23 (13.7) 145 (86.3) .001
Non-tumor Nasopharyngeal (n = 49) 18 (36.7) 31 (63.3) 28 (57.1) 21 (42.9)
Abbreviations: P positive, N negative
* Note: Chi-square test, p <0.05
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of Cks1 than the alive group (p < 0.001). However, no
significant correlation was found between the expression
of Cks1 and other clinicopathological features, including
age, gender, histological type and clinical stage (p > 0.05,
respectively). The expression of p27KIP1 was not related
to any of clinicopathological features. This result proved
that increased expression of Cks1 protein was associated
with lymph node metastasis and survival status.
Aberrant expression of Cks1 protein predicted poor
diagnosis in NPC
To further evaluate the effect of increased expression of
Cks1or decreased expression of p27kip1 in the survival of
NPC, the Kaplan-Meier survival curve of all 168 NPC
patients was constructed by the Kaplan-Meier analysis.
As shown in Fig. 2, Kaplan-Meier survival curves
depicted that overall survival (OS) in NPC patients with
Cks1 positive expression was shorter compared with the
negative ones (P < 0.001, log rank =16.466) (Fig. 2a), but
there was no significance between expression of p27kip1
and NPC patients survival rate (p > 0.05) (Fig. 2b). The
combined analysis of Cks1 and p27kip1 expression re-
vealed that the expression level of p27KIP1 protein did
not affect the relevance between Cks1 and the survival
of NPC patients (Fig. 2c). In addition, compared with
those patients without LNM, patients with LNM showed
a tendency of poor prognosis (P < 0.001, log rank =
19.556) (Fig. 2d). After patients being stratified by LNM,
patients with Cks1 positive expression showed signifi-
cantly shorter OS than negative group (P <0.001, log
rank = 15.056) (Fig. 2e), while the significance of p27KIP1
in NPC patients survival was not found (Fig. 2f ).
Furthermore, we carried out multivariate Cox propor-
tional hazard regression analysis to estimate the prog-
nostic value of Cks1 or p27kip1 protein in NPC. The
clinical stage, T-stage (volume of tumor), lymph node
metastasis status, histological type, treatment strategy,
age and gender, as well as expression of Cks1 and
p27kip1 proteins were included in the multivariate ana-
lysis of 168 cases of NPC. Shown in Table 4, results con-
firmed that increased expression of Cks1 was identified as
an independent poor prognostic factor for NPC (P < 0.05),
Table 2 The pairwise association between expression of Cks1
and p27kip1 in NPC
Cks1 p27kip1
Cks1
Spearman’s Correlation Coefficient Sig. (2-tailed)
1 −0.189*
p27kip1
Spearman’s Correlation Coefficient Sig. (2-tailed)
−0.189* 1
Note: Values are Spearman’s correlation coefficient
* Correlation is significant at the p <0.01 level (2-tailed)
Table 3 Association between expression of Cks1 and p27KIP1 and clinical pathological features of patients with NPC
Characteristics Cks1 p27kip1
P (%) N (%) p-value P (%) N (%) p-value
Age (yr)
≤ 50 (n = 101) 73 (72.3) 28 (27.7) .859 15 (14.9) 86 (85.1) .382
> 50 (n = 67) 50 (74.6) 17 (25.4) 8 (11.9) 59 (88.1)
Gender
Female (n = 41) 32 (78) 9 (22) .421 4 (9.8) 37 (90.2) .399
Male (n = 127) 91 (71.7) 36 (28.3) 19 (15.0) 108 (85.0)
Histological Type
DNC (n = 14) 11 (78.6) 3 (21.4) .636 3 (21.4) 11 (78.6) .379
UDNC (n = 154) 112 (72.7) 42 (27.3) 20 (13.0) 134 (87.0)
Clinical Stage
Stage I-II (n =45) 30 (66.7) 15 (33.3) .246 5 (11.1) 40 (88.9) .556
Stage III-IV (n =123) 93 (75.6) 30 (24.4) 18 (14.6) 113 (78.6)
LN Status
LNM (n = 125) 111 (88.8) 14 (11.2) .007* 16 (12.3) 109 (87.2) .567
No LNM (n = 43) 30 (69.8) 13 (30.2) 7 (16.3) 36 (83.7)
Survival Status
Alive (n = 94) 57 (60.6) 37 (39.4) .000* 13 (13.8) 81 (862) .953
Dead (n =74) 66 (89.2) 8 (10.8) 23 (13.7) 145 (86.3)
Abbreviations: DNKC differentiated non-keratinized nasopharyngeal carcinoma, UDNC undifferentiated non-keratinized nasopharyngeal carcinoma, LN lymph node,
LNM lymph node metastasis, P positive, N negative
Note: chi-square test, *: p < 0.05
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as did as clinical stage, treatment strategy and LNM status
(P < 0.05, respectively). However, neither expression of
p27kip1 protein or other clinicopathological features was
detected to be the independent prognostic factors for
NPC (P > 0.05, respectively). This result hinted that high
expression of Cks1 protein might be a poor prognostic
factor in NPC.
Discussion
The alterations of expression or activity of proteins
which is related to cell cycle regulation are of extensive
interest, because uncontrolled proliferation is a critical
character in tumor progression. Cyclin-dependent kinase
(CDK) inhibitor p27Kip1 inhibits the activity of G1-
cyclin–CDK complexes and arrests cell-cycle progres-
sion in G1 phase. P27Kip1 is degraded in the late G1
phase via the ubiquitin–proteasome pathway [17]. The
Cks1 protein is a member of the highly conserved family
of Cks/Suc1 proteins which interact with Cdks and par-
ticipates in numerous cellular processes including cell
proliferation, growth and survival [18, 19]. One of well
established mechanisms of Cks1 modulating cell cycle is
to bind with the C-terminal of Skp2 to degrade p27Kip1
and to promote cell cycle progression from G1 to S
phase [7, 8, 18]. Recent evidence has revealed that Cks1
is over-expressed in a majority of tumors, solid tumors
such as gastric carcinoma [20], oral squamous cell
Fig. 2 Kaplan-Meier curves for overall survival of the NPC patients. a Kaplan-Meier survival curves for OS in NPC patients with Cks1 positive and
negative expression. b Kaplan-Meier survival curves for OS in NPC patients with p27KIP1 positive and negative expression. c Kaplan-Meier survival
curves for OS in 4 group NPC patients: Cks1-positive & p27KIP1-negative, Cks1-positive & p27KIP1-positive, Cks1-negative & p27KIP1-negative and
Cks1-negative &p27KIP1-positive. d Kaplan-Meier survival curves for OS in NPC patients with and without LNM. e Kaplan-Meier survival curves for
OS in group of LNM patients with Cks1 positive and negative expression. f Kaplan-Meier survival curves for OS in group of LNM patients with
p27KIP1 positive and negative expression. Statistical significance was assessed using the log-rank test
Table 4 Summary of multivariate analysis of Cox proportional
hazard regression for overall survival in NPC
Parameter Wald Sig Exp
(B)
95.0% CI for Exp (B)
Lower upper
Cks1 6.185 .013 * 2.652 1.230 5.721
P27KIP1 1.174 .279 1.486 .726 3.042
T-stage 1.271 .260 .835 .611 1.142
Clinical Stage 7.624 .006 * 1.783 1.183 2.689
LNM Status 15.04 .000 * 7.086 2.635 19.06
Histological Type 2.101 .147 .496 .192 1.280
Treatment Strategy 8.461 .004 * 3.549 1.512 8.332
Age .000 .999 1.000 .607 1.646
Abbreviations: LNM lymph node metastasis, CI confidence interval, P positive,
N negative
Note: multivariate analysis of Cox regression,*p <0.05
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carcinoma [21], colorectal carcinoma [22], salivary gland
tumors [9], esophagus carcinomas [10], hepatocellular
carcinoma [11], breast cancer [12], non-small cell lung
carcinoma [23], and hematologic tumors, like lymphoma
[14], multiple myeloma [13]. In those studies, high ex-
pression of Cks1 is associated with tumor formation and
aggressiveness. It is frequently observed that high Cks1
expression is correlated with high SKP2 and low p27Kip1
and is associated with tumor progression in some cases.
Those studies coincide with our results and further indi-
cate the important roles of Cks1 in tumor progression.
In this study, we found that the expression of Cks1
increased in NPC tissue, and high expression of Cks1
protein was correlated with LNM status and survival
status in NPC patients. But, p27Kip1 expression was
not correlated with the clinicopathological characteris-
tics in NPC, although IHC analysis result showed that
p27Kip1 expression was attenuated in NPC patients
and statistical analysis data confirmed that the expres-
sion of p27kip1 was inversely related to Cks1 in NPC.
The non-significance of p27Kip1 in prognostic evaluation
of tumor has been observed in esophagus carcinomas
[10], hepatocellular carcinoma [11], and non-small cell
lung carcinoma [23] too. Those evidences support our re-
sults and suggest that Cks1 might influence progression of
NPC through p27KIP1-independent ways.
In fact, some studies also indicate Cks1 is involved in
regulating cell cycle transitions by other targets, not only
p27KIP1. For instance, Cks1 promotes cell to enter from
G0 to G1 by mediating the ubiquitination of CDK1 in-
hibitor p130 in breast cancer [15]. Besides the mecha-
nisms of regulating cell cycle, a few studies have
improved that Cks1 is required in cell transcriptional
events. Cdc20 has been reported to be a transcriptional
target of Cks1 [24]. Cks1 protein is primarily involved in
modulating the transcriptional activation of the APC/C
protein-ubiquitin ligase activator Cdc20 to promote mi-
tosis [24, 25]. Cks1 has also been reported to transcrip-
tionally regulate the expression of cdc2, cyclin B and
cyclin A in mammalian cells [26]. Moreover, the in-
volvement of Cks1 in MAPK [27], JAK-STAT [28]
and NF- κB [29] cell signaling pathways has been re-
ported recently. Cks1 influences cell proliferation and
apoptosis through activating the phosphorylation of
MEK1/2 and ERK1/2 in breast cancer, and the phosphor-
ylation of MEK1/2, ERK1/2 and STAT3 in multiple mye-
loma [28]. Our research results suggested that Cks1 might
promote NPC invasion and progression through multiple
ways, not only by p27Kip1-dependent mechanism.
In recent years, due to radiotherapy and chemother-
apy resistance, the effect of treatment in NPC is at a
standstill. Increased expression of Cks1 promotes the
radiation resistance ability of ESCC cells [30]. Cks1
over-expression leads to multidrug resistance in
multiple myeloma cells in vitro by activating MAPK
and STAT3 pathways [28]. But, enforced expression
of Cks1 enhanced chemotherapeutic sensitivity by
overriding DNA damage checkpoints in breast cancer
cell in vitro and in vivo [31]. These inconsistent re-
search results suggest that Cks1 protein might play
complex roles in mechanism of tumor cell tolerance
to radiotherapy and chemotherapy. Our research re-
sults uncovered that high expression of Cks1 was cor-
related with lymph node metastasis and survival rate
in NPC, which may offer potential target for effective
treatment in NPC.
Conclusion
In summary, we first reported that the expression of
Cks1 protein increased and p27KIP1 decreased in NPC.
Over-expression of Cks1 was associated with the poor
overall survival rate of NPC. Furthermore, multivariate
analysis suggested that high expression of Cks1 protein
might be regarded as the independent prognostic factor
for poor prognosis in NPC patients. These results may
provide novel clue for NPC therapy methods.
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